Skip to main content
. Author manuscript; available in PMC: 2015 Aug 11.
Published in final edited form as: Ann Emerg Med. 2013 Jan 30;61(4):414–420.e1. doi: 10.1016/j.annemergmed.2012.11.001

Table 2.

Intubation success stratified by patient, intubation, and operator characteristics.

Characteristics First-Pass Success Overall Success


GVL, % C-MAC, % OR (95% CI)* GVL, % C-MAC, % OR (95% CI)*
Sex
 Male 80 81 0.5 (0.3–1.0) 96 96 0.8 (0.3–2.4)
 Female 87 90 [Reference] 96 98 [Reference]
Trauma status
 Trauma 81 81 0.7 (0.4–1.2) 95 96 0.6 (0.2–1.5)
 Nontrauma 84 87 [Reference] 98 97 [Reference]
Number of DACs
 0 90 94 [Reference] 98 99 [Reference]
 1 91 85 0.6 (0.2–1.3) 100 96 0.6 (0.1–3.8)
 2 74 80 0.3 (0.1–0.6) 91 98 0.2 (0–1.2)
 3 or more 74 64 0.2 (0.1–0.4) 95 92 0.2 (0.1–1.1)
Reason for intubation
 Airway protection 84 89 [Reference] 96 99 [Reference]
 Respiratory failure 93 88 1.5 (0.6–3.4) 96 100 2.0 (0.3–16.4)
 Cardiac arrest 57 59 0.2 (0.1–0.4) 93 84 0.2 (0.1–0.7)
 Patient control 90 86 1.2 (0.4–3.1) 100 100 N/A
 Hypoxia 100 80 1.3 (0.2–10.6) 100 80 0.2 (0–2.1)
Reason for device
 Standard 90 92 [Reference] 98 98 [Reference]
 Difficult 78 74 0.3 (0.2–0.7) 95 94 0.3 (0.1–1.4)
 Education 93 88 0.8 (0.3–2.0) 100 98 1.0 (0.1–7.4)
Operator PGY
 EMR 1 74 75 [Reference] 96 975 [Reference]
 EMR 2 84 90 2.2 (1.2–4.0) 98 98 1.7 (0.4–6.8)
 EMR 3 or attending 86 84 2.0 (1.1–3.6) 94 95 0.6 (0.2–2.0)
Paralytic used
 None 65 64 [Reference] 93 87 [Reference]
 Rocuronium 89 88 4.1 (2.2–7.9) 98 99 6.6 (1.7–25.6)
 Succinylcholine 83 89 3.3 (1.8–6.1) 96 98 3.7 (1.3–11.1)
Sedative used
 None 66 65 [Reference] 91 87 [Reference]
 Etomidate 85 88 3.4 (1.9–6.1) 97 98 4.5 (1.7–12.1)
 Ketamine 83 85 2.9 (1.1–7.9) 100 100 N/A
 Propofol 100 89 8.0 (1.0–64.0) 100 100 N/A
 Other N/A 100 0.5 (0–8.9) 100 100 N/A
*

Univariate analysis.

Dropped because it predicted success perfectly.